Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 10/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.51 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.49 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23417761 | 0.84 | LTA4H (0.68) | LTA4HMAPT | |
| SCHEMBL176813 | 0.84 | LTA4H (0.91) | LTA4HALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL2522620 | 0.84 | LTA4H (0.91) | LTA4HALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL177182 | 0.83 | LTA4H (0.66) | LTA4HMEN1KMT2AMAPT | |
| SCHEMBL27981283 | 0.83 | LTA4H (0.66) | LTA4HMEN1KMT2AMAPT | |
| SCHEMBL31369727 | 0.83 | LTA4H (0.66) | LTA4HMEN1KMT2AALDH1A1SLC1A3 | |
| SCHEMBL31369744 | 0.82 | LTA4H (0.73) | LTA4HMEN1KMT2AFOLH1ALDH1A1 | |
| SCHEMBL10076188 | 0.81 | MAPT (0.65) | LTA4HSLC1A2SLC1A1POLBMAPT | |
| SCHEMBL6004419 | 0.80 | CASR (0.66) | LTA4H | |
| SCHEMBL11613830 | 0.80 | CASR (0.66) | LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | LTA4H 4516/4885MEN1 4354/4885KMT2A 3415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.